Cuba launches first nanopharmaceutical

Sep 23, 2012

Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.

"Its main advantages are that it can achieve the same favorable effect with a dose three times less powerful, using the most prescribed drug of its kind in its class, and while significantly reducing side effects," lead researcher Dario Lopez told the Communist Party newspaper Granma.

His research included design of the drug, also used to treat arthritis, "in a totally water soluble form, in which appears dissolved in the form of in microcapsules."

Nanotechnology is a field of applied science in which materials on a tiny scale—structures with at least one dimension sized from 1 to 100 nanometers—are manipulated for industrial, medical and other purposes.

Cuba has a biotech research industry focused largely on vaccines, which earns the Americas' only Communist-run country about $400 million a year.

Explore further: Researchers improve how a peptide can be delivered to the diseased heart tissue of mice via nanotechnology

add to favorites email to friend print save as pdf

Related Stories

Cuba to test new AIDS vaccine on humans

Mar 06, 2012

Cuba's top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana on Monday.

Cuba says US behind illegal wireless networks

Nov 14, 2011

Cuba accused the United States on Monday of enabling illegal Internet connections in its territory and said several people were arrested in April for profiting from the wireless networks.

Cuba declares cholera outbreak over

Aug 28, 2012

Cuba's health ministry said Tuesday the country's first cholera outbreak in 130 years is over after three deaths and more than 400 confirmed cases.

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

SteveL
not rated yet Sep 23, 2012
Congratulations to our neighbors to the South East. It's long past time we considered normalizing relations with our neighbor countries and a bit less time finding reasons to not get along.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.